Aclaris Therapeutics Inc
Biotechnology
Healthcare
ACRS
123 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.90
52 week high
4.59
high
1.97
52 week low
0.00
previous Close
1.93
P/E ratio
market cap
224 M
div yield
0
net incoming
-15.43 M
-2.28 %
net profit margin
-868.26 %
168.00 %
operating incoming
-18.41 M
-1.79 %
net change in cash
-4.96 M
-185.62 %
cash on hand
25.40 M
-16.32 %
cost of revenue
515 K
1.78 %
top